Reinhart Zachoval
Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort
Schnitzler F, Grüner N, Rust C, Guba M, Denk G, Zachoval R, Göke B, Tillack C, Beigel F, Olszak T, Angelberger M, Wolf C, Karbalai N, Habicht A, Fischereder M, Schönermarck U, Stallhofer J, Friedrich M, Brand S. Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort. PloS one 2015; 10:e0135807.
Aug 19, 2015Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort
Aug 19, 2015PloS one 2015; 10:e0135807
Schnitzler Fabian, Grüner Norbert, Rust Christian, Guba Markus, Denk Gerald, Zachoval Reinhart, Göke Burkhard, Tillack Cornelia, Beigel Florian, Olszak Torsten, Angelberger Marianne, Wolf Christiane, Karbalai Nazanin, Habicht Antje, Fischereder Michael, Schönermarck Ulf, Stallhofer Johannes, Friedrich Matthias, Brand Stephan
FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C
Heeg M, Spannagl M, Kauke T, Horster S, Schraut W, Raziorrouh B, Gerlach T, Jung M, Zachoval R, Grüner N, Ulsenheimer A, Diepolder H. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C. Gastroenterology 2009; 137:1280-8.e1-6.
Oct 1, 2009FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C
Oct 1, 2009Gastroenterology 2009; 137:1280-8.e1-6
Heeg Malte H J, Spannagl Michael, Kauke Teresa, Horster Sophia, Schraut Winfried, Raziorrouh Bijan, Gerlach Tilman, Jung Maria-Christina, Zachoval Reinhart, Grüner Norbert H, Ulsenheimer Axel, Diepolder Helmut M
Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine
Gruener N, Gerlach T, Ulsenheimer A, Diepolder H, Wierenga E, Zachoval R, Heeg M, Pape G, Jung M. Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine. Vaccine 2007; 25:4960-6.
Jun 21, 2007Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine
Jun 21, 2007Vaccine 2007; 25:4960-6
Gruener Norbert H, Gerlach Tilman, Ulsenheimer Axel, Diepolder Helmut M, Wierenga Eddy, Zachoval Reinhart, Heeg Malte, Pape Gerd Rudolf, Jung Maria-Christina
Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection
Lucas M, Santantonio T, Fidler S, Thimme R, Haberstroh A, Baumert T, Klenerman P, Diepolder H, Nitschko H, Obermeier M, Phillips R, Scriba T, Semmo N, Day C, Weber J, Schraut W, Pape G, Zachoval R, Ulsenheimer A, Pfafferot K, Heeg M, Gaudieri S, Grüner N, Rauch A, Gerlach T, Jung M. Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection. PloS one 2007; 2:e649.
Jan 1, 2007Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection
Jan 1, 2007PloS one 2007; 2:e649
Lucas Michaela, Santantonio Teresa, Fidler Sarah, Thimme Robert, Haberstroh Anita, Baumert Thomas F, Klenerman Paul, Diepolder Helmut M, Nitschko Hans, Obermeier Martin, Phillips Rodney, Scriba Thomas J, Semmo Nasser, Day Cheryl, Weber Jonathan N, Schraut Winfried, Pape Gerd R, Zachoval Reinhart, Ulsenheimer Axel, Pfafferot Katja, Heeg Malte H J, Gaudieri Silvana, Grüner Norbert, Rauch Andri, Gerlach Tilman, Jung Maria-Christina
Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment
Backmund M, Reimer J, Meyer K, Gerlach T, Zachoval R. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 40 Suppl 5:S330-5.
Apr 15, 2005Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment
Apr 15, 2005Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 40 Suppl 5:S330-5
Backmund Markus, Reimer Jens, Meyer Kirsten, Gerlach Tilman, Zachoval Reinhart
Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection
Ulsenheimer A, Pape G, Zachoval R, Schirren C, Heeg M, Schraut W, Santantonio T, Backmund M, Wächtler M, Gruener N, Jung M, Gerlach T, Diepolder H. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology (Baltimore, Md.) 2005; 41:643-51.
Mar 1, 2005Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection
Mar 1, 2005Hepatology (Baltimore, Md.) 2005; 41:643-51
Ulsenheimer Axel, Pape Gerd R, Zachoval Reinhart, Schirren Carl A, Heeg Malte H J, Schraut Winfried, Santantonio Teresa, Backmund Markus, Wächtler Martin, Gruener Norbert, Jung Maria-Christina, Gerlach Tilman, Diepolder Helmut M
Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation
Gruener N, Pape G, Schauer R, Baretton G, Diepolder H, Zachoval R, Gerlach T, Ulsenheimer A, Jung M, Schirren C. Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004; 10:1487-96.
Dec 1, 2004Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation
Dec 1, 2004Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004; 10:1487-96
Gruener Norbert Hubert, Pape Gerd Rudolf, Schauer Rolf, Baretton Gustavo, Diepolder Helmut Michael, Zachoval Reinhart, Gerlach Tilman, Ulsenheimer Axel, Jung Maria-Christina, Schirren Carl Albrecht
SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA
Vlotides G, Sörensen A, Kopp F, Zitzmann K, Cengic N, Brand S, Zachoval R, Auernhammer C. SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem Biophys Res Commun 2004; 320:1007-14.
Jul 30, 2004SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA
Jul 30, 2004Biochem Biophys Res Commun 2004; 320:1007-14
Vlotides George, Sörensen Astrid S, Kopp Florian, Zitzmann Kathrin, Cengic Neziha, Brand Stephan, Zachoval Reinhart, Auernhammer Christoph J
Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?
Berg T, Sarrazin C, Hinrichsen H, Buggisch P, Gerlach T, Zachoval R, Zeuzem S. Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?. Hepatology (Baltimore, Md.) 2004; 39:1456-7; author reply 1457-8.
May 1, 2004Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?
May 1, 2004Hepatology (Baltimore, Md.) 2004; 39:1456-7; author reply 1457-8
Berg Thomas, Sarrazin Christoph, Hinrichsen Holger, Buggisch Peter, Gerlach Tilman, Zachoval Reinhart, Zeuzem Stefan
Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination
Schirren C, Pape G, Nitschko H, Rau H, Schraut W, Baretton G, Diepolder H, Gruener N, Ulsenheimer A, Gerlach T, Zachoval R, Jung M. Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination. Journal of hepatology 2003; 39:397-404.
Sep 1, 2003Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination
Sep 1, 2003Journal of hepatology 2003; 39:397-404
Schirren Carl Albrecht, Pape Gerd Rudolf, Nitschko Hans, Rau Horst-Guenter, Schraut Winfried, Baretton Gustavo, Diepolder Helmut Michael, Gruener Norbert Hubert, Ulsenheimer Axel, Gerlach Tilman, Zachoval Reinhart, Jung Maria-Christina
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance
Gerlach T, Backmund M, Waechtler M, Schirren C, Schraut W, Ulsenheimer A, Jung M, Gruener N, Zachoval R, Diepolder H, Pape G. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003; 125:80-8.
Jul 1, 2003Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance
Jul 1, 2003Gastroenterology 2003; 125:80-8
Gerlach Tilman, Backmund M, Waechtler M, Schirren C Albrecht, Schraut Winfried W, Ulsenheimer Axel, Jung Maria-Christina, Gruener Norbert H, Zachoval Reinhart, Diepolder Helmut M, Pape Gerd R
Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C
Ulsenheimer A, Gerlach T, Gruener N, Jung M, Schirren C, Schraut W, Zachoval R, Pape G, Diepolder H. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology (Baltimore, Md.) 2003; 37:1189-98.
May 1, 2003Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C
May 1, 2003Hepatology (Baltimore, Md.) 2003; 37:1189-98
Ulsenheimer Axel, Gerlach Tilman, Gruener Norbert H, Jung Maria-Christina, Schirren Carl-Albrecht, Schraut Winfried, Zachoval Reinhart, Pape Gerd R, Diepolder Helmut M
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy
Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, Wiedenmann B, Hopf U, Zeuzem S. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology (Baltimore, Md.) 2003; 37:600-9.
Mar 1, 2003Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy
Mar 1, 2003Hepatology (Baltimore, Md.) 2003; 37:600-9
Berg Thomas, Sarrazin Christoph, Herrmann Eva, Hinrichsen Holger, Gerlach Tilman, Zachoval Reinhart, Wiedenmann Bertram, Hopf Uwe, Zeuzem Stefan
Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
Jung M, Zeuzem S, Trojan J, Whitehead E, Birtles E, Bailey J, Page M, Schirren C, Diepolder H, Gerlach T, Schraut W, Zachoval R, Grüner N, Pape G. Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers. Vaccine 2002; 20:3598-612.
Oct 4, 2002Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
Oct 4, 2002Vaccine 2002; 20:3598-612
Jung Maria-Christina, Zeuzem Stefan, Trojan Jörg, Whitehead Eve, Birtles Emma, Bailey John, Page Mark, Schirren Carl-Albrecht, Diepolder Helmut, Gerlach Tilman, Schraut Winfried, Zachoval Reinhart, Grüner Norbert, Pape Gerd R